Manulife (Manufacturers Life Insurance)’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,310
Closed -$69.1K 3016
2024
Q2
$69.1K Buy
+11,310
New +$93.9K ﹤0.01% 2918
2021
Q1
Sell
-16,665
Closed -$151K 3088
2020
Q4
$151K Buy
16,665
+2,132
+15% +$16.2K ﹤0.01% 2859
2020
Q3
$88K Hold
14,533
﹤0.01% 2819
2020
Q2
$119K Buy
+14,533
New +$108K ﹤0.01% 2694

Other funds holding FENC

Manulife (Manufacturers Life Insurance)'s FENC Position: Q3 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Fennec Pharmaceuticals (FENC) in Q3 2024, closing a stake of 11,310 shares — an estimated $69.1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FENC in Q2 2020 and held it in 4 quarters. The position peaked at $151K in Q4 2020. 63 funds tracked by Wall St. Rank hold FENC as of Q3 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Fennec Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 11,310 Fennec Pharmaceuticals shares in Q3 2024, an estimated $69.1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Fennec Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Fennec Pharmaceuticals position peaked at $151K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2024, filed 13 Nov 2024.